Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda

Hepatology

Volumn 27, Issue 3, 1998, Pages 848-852

  Lamoril, Jérôme ^a  

^a Ctr Français des Porphyries   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; FERRITIN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS G; HEPATITIS G VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PORPHYRIA CUTANEA TARDA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; FEMALE; FLAVIVIRIDAE; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; MALE; MIDDLE AGED; PORPHYRIA CUTANEA TARDA; PREVALENCE; PROSPECTIVE STUDIES; RNA, VIRAL;

EID: 0031891521     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270329     Document Type: Article

References (16)

1. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 1995:2103-2159.
2. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys2825Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997;349:321-323.
3. Daoud MS, Gibson LE, Daoud S, El-Azhary RA. Chronic hepatitis C and skin diseases: a review. Mayo Clin Proc 1995;70:559-564.
4. Cumber SC, Chopra S. Hepatitis C: a multifaceted disease. Ann Intern Med 1995;123:615-620.
5. Linnen J, Wages J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-508.
6. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;1:564-569.
7. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci U S A 1995;92:3401-3405.
8. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JWK, Kim JP. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997;336:747-754.
9. Loiseau P, Mariotti M, Corbi C, Ravera N, Girot R, Thauvin M, Portelette E, et al. Prevalence of hepatitis G virus RNA in French blood donors and recipients. Transfusion 1997;37:645-650.
10. Masuko K, Mitsui T, Iwano KK, Yamazaki C, Okuda K, Meguro T, Murayama N, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996;334:1485-1490.
11. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C [Letter]. N Engl J Med 1996;334:194-196.
12. De Lamballerie X, Charrel RN. Hepatitis GB virus in patients on hemodialysis [Letter]. N Engl J Med 1996;334:1549.
13. Nubling CM, Lower J. GB-C genomes in a high-risk group, in plasma pools, and in intravenous immunoglobulin (letter). Lancet 1996;347:68.
14. Alter MJ, Gallagher M, Morris TT, Moyer LA, Meeks EL, Krawczynski K, Kim JP, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997;336:741-746.
15. Martinot M, Marcellin P, Boyer N, Detmer J, Pouteau M, Castelnau C, Degott C, et al. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-α in patients with chronic hepatitis C. Ann Intern Med 1997;126:874-881.
16. Fischler B, Lara C, Chen M, Sönnerborg, Nemeth A, Sällberg M. Genetic evidence for mother-to-infant transmission of hepatitis G virus. J Infect Dis 1997;176:281-285.